Blog
  • Omnichannel
  • Oncology
  • Conferences
  • Media Tracking
  • Ferma.AI
  • Launch Excellence
  • HCP-PT
  • Talent Community
Manoj Hariharaputhiran

Manoj Hariharaputhiran

Chennaii •
38 posts •
Evaluating Messaging Benchmarks Across Key Therapeutic Areas: Oncology, Rare Disease, and Immunology
Promotional Tracking

Evaluating Messaging Benchmarks Across Key Therapeutic Areas: Oncology, Rare Disease, and Immunology

Following our prior analysis of overarching trends in healthcare professional (HCP) message recall and effectiveness across the pharmaceutical market, we’ve now explored three key therapeutic areas in greater depth: Oncology, Rare Disease,

  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
  • Neeharika Nori
    Neeharika Nori
  • Anna Chubaeva
10 min read
RFK Jr. Nomination to lead HHS
Promotional Tracking

RFK Jr. Nomination to lead HHS

Gain critical insights into the perspectives of healthcare professionals (HCPs) regarding Robert F. Kennedy Jr.'s nomination as Secretary of Health and Human Services (HHS). This report highlights key findings from a survey

  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
2 min read
Global Pharma Manufacturer Perception Tracker Oncology
Oncology

Global Pharma Manufacturer Perception Tracker Oncology

Every day, over 54,500 people are diagnosed with cancer and more than 26,000 succumb. Pharma leaders are answering the call by increasing investments in cancer drug research and developing personalized treatments,

  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
  • Varsha Sundaram
    Varsha Sundaram
  • Neen Anna Alexander
2 min read
Global Pharma Manufacturer Perception: Vaccines
Promotional Tracking

Global Pharma Manufacturer Perception: Vaccines

The vaccine industry has undergone an unprecedented transformation in the last 5 years, driven by significant technological advancements and a renewed global focus on public health and immunization. Breakthroughs in multiple areas like

  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
  • Varsha Sundaram
    Varsha Sundaram
  • Neen Anna Alexander
2 min read
2024 Lung Cancer Developments
Promotional Tracking

2024 Lung Cancer Developments

ZOOMRX Global Oncology Panel’s Perspectives The last couple of months have brought some high-profile developments in non-small cell lung cancer (NSCLC) including critical data released at the World Conference on Lung Cancer

  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
  • Vinoth Rajapandian
  • Kinga Zapert
    Kinga Zapert
6 min read
Oncology Pipeline Perceptions - Assessing HCP Excitement
Brand Builder

Oncology Pipeline Perceptions - Assessing HCP Excitement

Genentech and Jazz tops among the list of most exciting oncology pipeline assets The Future of Oncology: Which Treatments Excite Oncologists? In the ever-evolving landscape of cancer treatment, the pipeline of new therapies

  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
  • Dan Callahan
5 min read
Hopes and Hurdles: Rare Disease Management
News

Hopes and Hurdles: Rare Disease Management

Creutzfeldt-Jakob disease is a degenerative brain disorder. It is fatal and occurs in 1-2 persons per 1 million population every year. Pulmonary arterial hypertension is a progressive disorder characterized by high blood pressure,

  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
  • Kazim Nawaz
    Kazim Nawaz
5 min read
Four Myths in HCP-Sales Rep Engagements
Promotional Tracking

Four Myths in HCP-Sales Rep Engagements

Stirring the Hornet’s Nest Engaging with healthcare professionals (HCPs) through sales representative interactions is like a delicate dance. There are established norms & firm beliefs on how it is being done. Challenging those

  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
  • Varsha Sundaram
    Varsha Sundaram
  • Akshay Kanna
    Akshay Kanna
4 min read
Driving Successful HCP-Sales Rep 'Engagements : 2023' Lookback PET Report
Promotional Tracking

Driving Successful HCP-Sales Rep 'Engagements : 2023' Lookback PET Report

The what and how behind the successful engagements and their trends over half a decade Understanding the Ever-Evolving HCP-Sales Rep Engagements . As we step into 2024, we look to understand 1. How HCP-Sales

  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
2 min read
Oncology Manufacturers' Perception - Insights from the Healthcare Frontline
Oncology

Oncology Manufacturers' Perception - Insights from the Healthcare Frontline

Leaders of Oncologist’s Perceptions: Who are they and what sets them apart In the highly competitive oncology therapeutics landscape, there is a direct correlation between oncologists’ preferences and financial success. That makes

  • Karni Medh
    Karni Medh
  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
5 min read
Thriving Against the Odds - A Case study
Promotional Tracking

Thriving Against the Odds - A Case study

An Emerging Biopharma’s David vs. Goliath story in the Post Launch Space Problem: Respiratory diseases are one of the leading causes of death and hospital admissions in the US. This market is

  • Varsha Sundaram
    Varsha Sundaram
  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
1 min read
Mindshare Masters: Top Oncology Brands that Oncologists Trust
Oncology

Mindshare Masters: Top Oncology Brands that Oncologists Trust

Have you ever wondered which oncology brands truly dominate and capture the mindshare oncologists in the ever-evolving field of oncology? With a staggering 100+ new molecular entities approved by the FDA (Fed­er­

  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
  • Karni Medh
    Karni Medh
3 min read
ASCO 2023 : From the Oncologists’ Perspective
News

ASCO 2023 : From the Oncologists’ Perspective

ASCO Annual Meeting 2023 led with the theme of Improving Patients' Lives Through Collaboration, Research, and Innovation, creating positive experiences among those who attended and generating excitement about practice-changing data. The ZoomRx survey

  • Hari Vignesh
    Hari Vignesh
  • Brooke Nelson
  • Kinga Zapert
    Kinga Zapert
  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
4 min read
Continuing the Launch Buzz: A Winning Game Plan
Oncology

Continuing the Launch Buzz: A Winning Game Plan

Three Keys for Sales Rep Conversations to Keep the Launch Momentum Going Introduction: Successfully launching a pharmaceutical product is incredibly challenging, time-consuming—and costly. The stakes are high, the competition is fierce, and

  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
  • Anu Priya
2 min read
What HCPs Really Think: A Revealing Look at Industry Leaders & Challengers in 5 Therapeutic Areas

What HCPs Really Think: A Revealing Look at Industry Leaders & Challengers in 5 Therapeutic Areas

Healthcare providers (HCPs) are crucial decision-makers in prescribing and recommending treatments to patients. As such, their perceptions and opinions of pharmaceutical manufacturers and their products are highly relevant. Recent research indicates that two-thirds

  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
  • Karni Medh
    Karni Medh
6 min read
Meet the Top 5 Oncology Pharmaceutical Manufacturers that Excel with MSL Guidance
Research

Meet the Top 5 Oncology Pharmaceutical Manufacturers that Excel with MSL Guidance

The oncology field is rapidly evolving, with groundbreaking CAR-T cell therapies and accessible biosimilars providing new hope for patients. However, these changes also bring new challenges in understanding and effectively utilizing these treatments.

  • Rakshana Gajendra
    Rakshana Gajendra
  • Laxmanan CJ
    Laxmanan CJ
  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
  • Athirai Valluvan
5 min read
Zynyz for Merkel Cell Carcinoma: A Highly Effective but Little Known Treatment Option?
Launch Excellence

Zynyz for Merkel Cell Carcinoma: A Highly Effective but Little Known Treatment Option?

Merkel Cell Carcinoma (MCC) is a rare and aggressive form of skin cancer that can be challenging to treat. Until recently, treatment options were limited, but with the advent of immunotherapy, new therapies

  • Karni Medh
    Karni Medh
  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
2 min read
Airsupra: The Rescue Inhaler That Helps Manage Asthma Symptoms
Launch Excellence

Airsupra: The Rescue Inhaler That Helps Manage Asthma Symptoms

Asthma is a chronic respiratory disease that affects millions of people worldwide. It causes inflammation and narrowing of the airways, leading to symptoms such as wheezing, shortness of breath, coughing, and chest tightness.

  • Karni Medh
    Karni Medh
  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
2 min read
Rykindo: A New Long-Acting Injectable Formulation of Risperidone for Schizophrenia and Bipolar I Disorder
Launch Excellence

Rykindo: A New Long-Acting Injectable Formulation of Risperidone for Schizophrenia and Bipolar I Disorder

The pharmaceutical industry is constantly evolving, and one of the latest additions to the market is Rykindo, a long-acting injectable formulation of risperidone. Risperidone is an atypical antipsychotic medication used for the treatment

  • Karni Medh
    Karni Medh
  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
2 min read
Jaypirca: A Fresh Approach to Later-Line MCL Treatment
Launch Excellence

Jaypirca: A Fresh Approach to Later-Line MCL Treatment

Jaypirca (pirtobrutinib) is a novel, non-covalent Bruton's tyrosine kinase (BTK) inhibitor indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic

  • Karni Medh
    Karni Medh
  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
2 min read
Leqembi's First 2 Months on the Market: Neurologists Feedback
Launch Excellence

Leqembi's First 2 Months on the Market: Neurologists Feedback

Leqembi (lecanemab) is a new Alzheimer's disease treatment option from Biogen/Eisai. The drug has a unique mechanism of action that is thought to slow down the progression of the disease by neutralizing

  • Karni Medh
    Karni Medh
  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
2 min read
The Latest Addition to Diabetes Treatment: A Deep Dive into Brenzavvy
Launch Excellence

The Latest Addition to Diabetes Treatment: A Deep Dive into Brenzavvy

Type 2 diabetes is a chronic disease that affects millions of people worldwide. It is characterized by high levels of sugar in the blood due to the body's cells resisting the normal effect

  • Karni Medh
    Karni Medh
  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
2 min read
Launch Excellence

Hope for Patients with Anemia of CKD: FDA Approves Jesduvroq

GSK plc has announced the FDA approval of Jesduvroq (daprodustat) for the treatment of anaemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least four months.

  • Karni Medh
    Karni Medh
  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
2 min read
Pharma Marketers' Point of View: The Evolution of the Pharma Promotional Landscape
Promotional Tracking

Pharma Marketers' Point of View: The Evolution of the Pharma Promotional Landscape

Highlight products’ superiority and differentiability Your browser does not support the audio element. Answer questions and/or solve problems Your browser does not support the audio element. Deliver newer data, such as product

  • Varsha Sundaram
    Varsha Sundaram
  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
17 min read
Physicians' View of the Industry Giants:
Ranking the Top Pharma Companies
Customer Engagement

Physicians' View of the Industry Giants: Ranking the Top Pharma Companies

The pharmaceutical industry is constantly evolving, and the perceptions of healthcare professionals (HCPs) play a critical role in shaping the public's trust and acceptance of drugs. To understand how physicians perceive the top

  • Karni Medh
    Karni Medh
  • Manoj Hariharaputhiran
    Manoj Hariharaputhiran
2 min read

All rights reserved ZoomRx - 2020.   Privacy Policy


HOME
PERSPECTIVES
PANELISTS
CAREERS